Katharine Yao to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Katharine Yao has written about Chemotherapy, Adjuvant.
Connection Strength
1.478
-
The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):164-172.
Score: 0.527
-
Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2014 Sep; 21(9):2920-7.
Score: 0.411
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
Score: 0.148
-
The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. Ann Surg Oncol. 2017 Oct; 24(11):3157-3166.
Score: 0.129
-
Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May; 115(6):668-676.
Score: 0.125
-
Multidisciplinary treatment of primary melanoma. Surg Clin North Am. 2009 Feb; 89(1):267-81, xi.
Score: 0.072
-
A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2018 May; 25(5):1304-1311.
Score: 0.033
-
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. JAMA Oncol. 2017 Jul 01; 3(7):928-935.
Score: 0.032